Navigate
X
    QualityStocks
  • 17 years ago

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC)

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), a diversified biopharmaceutical company, is focused on discovering, developing, and commercializing innovative mechanism-targeted drugs to treat human cancers and other serious disorders. The company’s strategic goal is to discover and develop oral anticancer agents that target the cell cycle with the intent to slow the growth of tumors or even shrink their size while enhancing the patient’s quality of life. For further information, visit the Company’s web site at www.cyclacel.com.

Tags Rodman & Renshaw
Related Post
  1. QualityStocksNewsBreaks – Powering AI: Nicola Mining Inc.’s (TSX.V: NIM) (OTCQB: HUSIF) Copper Project Aligns with Data Center Surge

    As artificial intelligence (“AI”) continues to revolutionize industries, the infrastructure supporting its growth has become…

  2. Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Breaks Ground on REE Processing Facility, Pioneers Domestic Supply Chain

    The company announced the groundbreaking of its Louisiana Strategic Metals Complex (“SMC”) in Alexandria. The…

  3. NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100

    The new FDA voucher program aims to speed approval of drugs aligned with national health…